1. Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
   Yang Cheng et al, 2021, Frontiers in Oncology CrossRef
2. SPP1, a potential therapeutic target and biomarker for lung cancer: functional insights through computational studies
   Yamuna Annadurai et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
3. Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications
   Melisa B. Nicoud et al, 2019, Frontiers in Pharmacology CrossRef
4. Artificial intelligence to deep learning: machine intelligence approach for drug discovery
   Rohan Gupta et al, 2021, Molecular Diversity CrossRef
5. In silico modeling and molecular docking insights of kaempferitrin for colon cancer-related molecular targets
   Mydhili Govindarasu et al, 2021, Journal of Saudi Chemical Society CrossRef
6. Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's Syndrome
   Elif Kubat Oktem et al, 2022, OMICS: A Journal of Integrative Biology CrossRef
7. Travma Sonrası Stres Bozukluğu (TSSB) Tedavisine Yönelik Moleküler Hedefler ve Yeniden Konumlandırılan İlaçlar
   Elıf KUBAT OKTEM, 2023, Afyon Kocatepe University Journal of Sciences and Engineering CrossRef
8. Construction of a circRNA-miRNA-mRNA Regulatory Network Reveals Potential Mechanism and Treatment Options for Osteosarcoma
   Yi He et al, 2021, Frontiers in Genetics CrossRef
9. Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation
   Dan Zou et al, 2021, Frontiers in Oncology CrossRef
10. Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping
    Yao Xiao et al, 2022, Cancers CrossRef